ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹538 Cr | ₹1,065 Cr | ₹486 Cr | ₹292 Cr | ₹378 Cr |
What is the latest Cash Flow from Operating Activities ratio of ERIS LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹538 Cr |
| Mar2025 | ₹1,065 Cr |
| Mar2024 | ₹486 Cr |
| Mar2023 | ₹292 Cr |
| Mar2022 | ₹378 Cr |
How is Cash Flow from Operating Activities of ERIS LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹538 Cr | -49.48 | |
| Mar2025 | ₹1,065 Cr | 119.13 | |
| Mar2024 | ₹486 Cr | 66.59 | |
| Mar2023 | ₹292 Cr | -22.87 | |
| Mar2022 | ₹378 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹15,979.6 Cr | -1.8% | -12.1% | -27.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -1.8% |
-12.1% |
-27.8% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses